ProChon Biotech Ltd. Appoints Brian Callahan as Executive Vice President, Regulatory & Quality Affairs

WOBURN, Mass.--(BUSINESS WIRE)--ProChon Biotech, Ltd., an innovator of tissue regenerative technologies that are being developed to relieve pain and restore the mobility and quality-of-life for sufferers of articular cartilage injuries, today announced that Brian Callahan has joined the Company in the role of Executive Vice President, Regulatory and Quality Affairs.

MORE ON THIS TOPIC